Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF EQUITY (Unaudited)

v3.21.2
CONSOLIDATED STATEMENTS OF EQUITY (Unaudited) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Noncontrolling Interest
Total
Beginning balance, shares at Mar. 31, 2019 1,266,979        
Beginning balance, value at Mar. 31, 2019 $ 1,267 $ 108,076,275 $ (105,652,433) $ (126,031) $ 2,299,078
Issuances of common stock for cash under at the market program, shares 161,149        
Issuances of common stock for cash under at the market program, value $ 162 895,869 896,031
Loss on debt extinguishment 447,011 447,011
Issuances of common stock for cash under warrant exercises, shares 2,700,000        
Issuances of common stock for cash under warrant exercises, value $ 2,700 3,804,462 3,807,162
Issuance of common shares upon vesting of restricted stock units, shares 12,393        
Issuance of common shares upon vesting of restricted stock units, value $ 12 (40,950) (40,938)
Proceeds from the issuance of common stock in public offerings, net, shares 5,218,712        
Proceeds from the issuance of common stock in public offerings, net, value $ 5,219 7,451,096 7,456,315
Issuances of common stock upon warrant exchanges, shares 3,992        
Issuances of common stock upon warrant exchanges, value $ 4 (51,194) (51,190)
Par value of DTC roundup of shares following reverse split, shares 3,946        
Par value of DTC roundup of shares following reverse split, value $ 4 (4)
Adjustment, shares (298)        
Adjustment, value
Stock based compensation expense 843,998 843,998
Net loss (6,373,948) (6,093) (6,380,041)
Ending balance, shares at Mar. 31, 2020 9,366,873        
Ending balance, value at Mar. 31, 2020 $ 9,368 121,426,563 (112,026,381) (132,124) 9,277,426
Issuances of common stock for cash under at the market program, shares 2,685,600        
Issuances of common stock for cash under at the market program, value $ 2,686 7,258,183 7,260,869
Issuance of common shares upon vesting of restricted stock units and net stock option exercise, shares 98,124        
Issuance of common shares upon vesting of restricted stock units and net stock option exercise, value $ 98 (132,625) (132,527)
Stock based compensation expense 779,421 779,421
Net loss (7,886,709) (4,790) (7,891,499)
Ending balance, shares at Mar. 31, 2021 12,150,597        
Ending balance, value at Mar. 31, 2021 $ 12,152 $ 129,331,542 $ (119,913,090) $ (136,914) $ 9,293,690